004 — Washington D.C., District of Columbia

004 is a clinical research site located in Washington D.C., District of Columbia, United States 20007.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

004 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Advanced Solid Tumor.

Sponsors: MediLink Therapeutics (Suzhou) Co., Ltd..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 004?

004 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 004 conducted?

004 has 1 clinical trials on record, with 1 currently active. Their work covers Advanced Solid Tumor.

Is 004 accredited by Crixeo Health?

004 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 004?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.